Author: <span>Fran Mannino</span>

Baylor Study: Mesothelioma ‘Staged Surgical Approach’ Increases Survival

Select patients diagnosed with mesothelioma cancer in both the thoracic and abdominal cavities still can achieve an extended survival if their treatment center performs the preferred types of aggressive surgery, according to a recent study at Baylor College of Medicine in Houston. Patients undergoing bicavitary cytoreductive surgery that includes the lung-sparing, extended pleurectomy and decortication […]

The post Baylor Study: Mesothelioma ‘Staged Surgical Approach’ Increases Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

UK Citizens Filing Asbestos Talc Claims In U.S. Courts

Residents of the United Kingdom have been among the growing number of personal injury plaintiffs filing lawsuits in U.S. courts, attributing their diagnoses of mesothelioma cancer to asbestos-contaminated talc. That should come as no surprise. With the world’s highest per capita incidence rate of mesothelioma, the UK is contributing to the changing face of asbestos […]

The post UK Citizens Filing Asbestos Talc Claims In U.S. Courts appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Avon Hit With $52.1M Verdict for Asbestos-Contaminated Talc

A California jury awarded $52.1 million to an Arizona woman diagnosed with mesothelioma cancer. The multimillion-dollar verdict combines damages against cosmetics giant Avon and a forklift manufacturer. Attorneys for Rita-Ann Chapman said she had been using Avon talc products contaminated with asbestos for much of her life. Chapman is 76. She blamed additional secondhand asbestos […]

The post Avon Hit With $52.1M Verdict for Asbestos-Contaminated Talc appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Dangers of Legacy Asbestos Detailed in UK Study

A recently published study from the United Kingdom has shown that legacy asbestos lingering in commercial and residential construction is more dangerous than expected.  In what is believed to be the largest study in the world of legacy asbestos, researchers found that almost two-thirds of it had aged enough, or was damaged enough, for fibers […]

The post Dangers of Legacy Asbestos Detailed in UK Study appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma Surgery With Immunotherapy Proves Effective in Study

An immunotherapy combination given before aggressive surgery has shown impressive effectiveness in extending survival for pleural mesothelioma patients in a recent phase II clinical trial at Baylor College of Medicine. The combination of immune checkpoint inhibitors durvalumab and tremelimumab showed an ability to effectively alter the intratumoral immune system and make surgery more effective. This […]

The post Mesothelioma Surgery With Immunotherapy Proves Effective in Study appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Study: Early Mesothelioma HIPEC Surgery Extends Survival

Sooner is better when it comes to aggressively treating peritoneal mesothelioma cancer with a combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Waiting could cost a patient months of survival. Rejecting surgery could cost them years. The Journal of Gastrointestinal Surgery published a study in November that showed for the first time to what degree […]

The post Study: Early Mesothelioma HIPEC Surgery Extends Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

VA Disability Rates Rise; Veterans With Mesothelioma Benefit

The U.S. Department of Veterans Affairs has increased its monthly payments to disabled veterans by 8.7%, the largest annual increase in 40 years. Veterans who developed disabilities caused by asbestos exposure during military service – including mesothelioma cancer – are among those receiving the increase, which began on Dec. 1. VA disability payout increases are […]

The post VA Disability Rates Rise; Veterans With Mesothelioma Benefit appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Honeywell to Fund Asbestos Trust With $1.3 Billion

To eliminate future funding obligations, Honeywell International Inc. has agreed to a one-time, lump sum payment of $1.325 billion to the asbestos trust fund it first established in 2013. If approved by the U.S. Bankruptcy Court for the Western District of Pennsylvania, the buyout agreement would likely end any additional asbestos-related liabilities for Honeywell. The […]

The post Honeywell to Fund Asbestos Trust With $1.3 Billion appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Looking Beyond Clinical Trials for Mesothelioma Treatment

Clinical trial results should not always be the guiding force when a mesothelioma cancer patient and their medical team determine what therapy path to take, according to one recent study. A look at real-world populations might be just as important. A research team at the University of Pennsylvania Department of Medicine has made the point […]

The post Looking Beyond Clinical Trials for Mesothelioma Treatment appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Global Mesothelioma Cases Nearly Double Over 30 Years

The number of people in the world diagnosed annually with mesothelioma cancer has almost doubled in the last 30 years, accentuating the need for more effective and better coordinated efforts to end this preventable, global health problem. Almost 35,000 people were diagnosed with mesothelioma in 2019, compared to an estimated 19,000 in 1990, according to […]

The post Global Mesothelioma Cases Nearly Double Over 30 Years appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Latest Study Compares Major Pleural Mesothelioma Surgeries

Mesothelioma patients may benefit more from aggressive extrapleural pneumonectomy surgery than from the lung-sparing pleurectomy and decortication currently being recommended as an alternative by many specialists today. According to the most recent study from Italy, extrapleural pneumonectomy, or EPP, allowed mesothelioma patients diagnosed with high symptom burden to live a longer, better-quality life than with […]

The post Latest Study Compares Major Pleural Mesothelioma Surgeries appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Congress Resumes Asbestos Ban Efforts After ProPublica Report

U.S. lawmakers and public health advocates have renewed their call for Congress to pass a long-awaited legislative ban of asbestos, sparked by the most recent news detailing the damage still being done by the toxic mineral. ProPublica, a nonprofit online news organization, chronicled the health effects stemming from an upstate New York industrial manufacturing plant […]

The post Congress Resumes Asbestos Ban Efforts After ProPublica Report appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

New Research Focuses on Mesothelioma Brain Metastasis

Distant metastasis is common with malignant pleural mesothelioma – more than 60% of patients experience it – but rarely is it found around the brain. A new study by a team of radiation oncologists in Great Britain, however, suggests that physicians should increase their focus on potential cerebral metastasis in mesothelioma patients. “Patients will continue […]

The post New Research Focuses on Mesothelioma Brain Metastasis appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Study: Cancer Enzyme Slows Growth of Pleural Mesothelioma

Patients with pleural mesothelioma may extend their survival by an estimated 30% when the latest anti-cancer enzyme is added to standard chemotherapy, according to a recently completed study. AGI-PEG 20 showed unprecedented effectiveness when treating patients with sarcomatoid mesothelioma and biphasic mesothelioma – the most treatment-resistant subtypes – in an international, multicenter, phase II/III clinical […]

The post Study: Cancer Enzyme Slows Growth of Pleural Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Orphan Drug Designation Given to New Mesothelioma CAR T-Cell Therapy

In early 2023, the world-class Hospital of the University of Pennsylvania will open a groundbreaking clinical trial for mesothelioma patients utilizing a next-generation immunotherapy with a novel delivery platform. The U.S. Food and Drug Administration cleared the path in September by granting orphan drug designation for SynKIR-110, a CAR T-cell therapy designed to target solid […]

The post Orphan Drug Designation Given to New Mesothelioma CAR T-Cell Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.